Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
European Journal of Immunology
|
November 11, 1999
FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3
S Xiao, K Matsui, A Fine, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1995
Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen
R Ettinger, D J Panka, J K Wang, et al.
The Journal of Experimental Medicine
|
October 1, 1979
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells
J Z Weinberger, R N Germain, S T Ju, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1997
Proteasome regulation of activation-induced T cell death
H Cui, K Matsui, S Omura, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1993
Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis
V K Kuchroo, C A Martin, J M Greer, et al.
Annals of the New York Academy of Sciences
|
April 5, 1997
Unique site of autoantibody production in Fas-deficient mice
B A Jacobson, L C Foote, D J Panka, et al.
The EMBO Journal
|
April 1, 1991
The CD3-gamma and CD3-delta subunits of the T cell antigen receptor can be expressed within distinct functional TCR/CD3 complexes
B Alarcón, S C Ley, F Sánchez-Madrid, et al.
Annales De L'Institut Pasteur. Immunologie
|
March 1, 1986
Activation of hybridoma macrophages
C A Martin, F Falkenberg, U Willmer, et al.
Cellular Immunology
|
February 1, 1996
Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation
H Cui, M el-Khatib, D H Sherr, et al.
Cellular Immunology
|
February 1, 1996
Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function
H Cui, D H Sherr, M el-Khatib, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
European Journal of Immunology
|
November 11, 1999
FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3
S Xiao, K Matsui, A Fine, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1995
Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen
R Ettinger, D J Panka, J K Wang, et al.
The Journal of Experimental Medicine
|
October 1, 1979
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells
J Z Weinberger, R N Germain, S T Ju, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 8, 1997
Proteasome regulation of activation-induced T cell death
H Cui, K Matsui, S Omura, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 15, 1993
Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis
V K Kuchroo, C A Martin, J M Greer, et al.
Annals of the New York Academy of Sciences
|
April 5, 1997
Unique site of autoantibody production in Fas-deficient mice
B A Jacobson, L C Foote, D J Panka, et al.
The EMBO Journal
|
April 1, 1991
The CD3-gamma and CD3-delta subunits of the T cell antigen receptor can be expressed within distinct functional TCR/CD3 complexes
B Alarcón, S C Ley, F Sánchez-Madrid, et al.
Annales De L'Institut Pasteur. Immunologie
|
March 1, 1986
Activation of hybridoma macrophages
C A Martin, F Falkenberg, U Willmer, et al.
Cellular Immunology
|
February 1, 1996
Characterization of lpr-derived T cell hybridomas: Fas-deficient hybridomas are deathless, growth-arrested, and cytotoxic upon activation
H Cui, M el-Khatib, D H Sherr, et al.
Cellular Immunology
|
February 1, 1996
Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function
H Cui, D H Sherr, M el-Khatib, et al.
Page
of 11